RetinalGenix Technologies (RTGN) Cash & Equivalents (2020 - 2026)
RetinalGenix Technologies' Cash & Equivalents came in at $27,232 for Q2 2026, compared with $839.00 a year earlier.
Powered by 
Analysis
RetinalGenix Technologies (RTGN) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, RetinalGenix Technologies' Cash & Equivalents was $14,774, up 143.8% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 46.1% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $6,060 in FY2024, $38.00 in FY2022 (-99.2%) and $4,947 in FY2021 (+122.9%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q3 2024.
- Year-over-year, Cash & Equivalents increased in 1 of the last five quarters, with an average decline of 48.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2024 (growth of 574.5%), and the weakest in Q3 2025 (a decline of 99.9%).
- Business Quant data shows RTGN's Cash & Equivalents at $180.00 (Q1 2026), $14,774 (Q4 2025) and $92.00 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 708.00 Mn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 2.91 Bn |
| 10 | RetinalGenix Technologies | 75.19 Mn | 75.14 Mn | - | 27,232.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27,232.00 |
| Mar 31, 2026 | 180.00 |
| Dec 31, 2025 | 14,774.00 |
| Sep 30, 2025 | 92.00 |
| Jun 30, 2025 | 839.00 |
| Mar 31, 2025 | 3,711.00 |
| Dec 31, 2024 | 6,060.00 |
| Sep 30, 2024 | 79,089.00 |
| Jun 30, 2024 | 86,913.00 |
| Mar 31, 2024 | 50,386.00 |
| Sep 30, 2023 | 44.00 |
| Jun 30, 2023 | 1,913.00 |
| Mar 31, 2023 | 7,470.00 |
| Dec 31, 2022 | 38.00 |
| Sep 30, 2022 | 3,632.00 |
| Jun 30, 2022 | 27.00 |
| Mar 31, 2022 | 2,555.00 |
| Dec 31, 2021 | 4,947.00 |
| Sep 30, 2021 | 36,578.00 |
| Dec 31, 2020 | 2,219.00 |
API Access
RetinalGenix Technologies Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();